Searched for
MANKIND PHARMA EXPORTS
Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 croreMankind Pharma shares jumped nearly 8% after the company reported a 38% year-on-year rise in Q2 profit to Rs 716 crore. Revenue grew 17%, s...
Mankind Pharma shares key business developments from Q2 & H1 of FY27The company outperformed the market by 1.1 times in both chronic and acute therapies. Cardiac and anti-diabetes brands registered growth of...
CPHI Milan: Beyond generics, how Indian pharma is rewriting its global playbookAt CPHI Milan, Indian pharma players are looking beyond traditional exports, using partnerships, licensing, CDMO, and differentiated produc...
When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...
Mankind Pharma shares jump 2% as Morgan Stanley initiates coverage with Overweight call. Check target, upsideMankind Pharma share price surged 2% after Morgan Stanley initiated coverage with an 'Overweight' rating and a Rs 2,500 target price, citin...
Mankind Pharma shares in focus after Q3 net profit drops 16% YoY to Rs 385 croreMankind Pharma's shares are in focus following a 16.5% YoY decline in Q3 net profit to Rs 385 crore, despite strong revenue growth of 24%. ...
Mankind Pharma Q3 Results: Profit falls 16% to Rs 384 croreMankind Pharma on Thursday said its consolidated net profit declined 16.5 per cent to Rs 384 crore in the third quarter ended December 31, ...
Mankind Pharma shares gain over 6% as profit jumps nearly 30% in Q2Mankind Pharma's shares surged by 6% after reporting a 29% rise in Q2 profits, reaching ₹658.88 crore. The company attributed this growth t...
Mankind Pharma Q2 Results: Net profit rises 29% to Rs 659 crore, revenue up 13%Mankind Pharma witnessed a 29% surge in consolidated net profit, reaching Rs 658.88 crore in the second quarter, ending September 2024. Thi...
CCI clears Rs 13,630-cr Mankind Pharma-Bharat Serums Vaccines dealThe Competition Commission of India has approved Mankind Pharma's Rs 13,630 crore acquisition of Bharat Serums and Vaccines. This acquisiti...
Mankind Pharma shares drop 2% despite 10% YoY Q1 PAT growth. Buy, sell, or hold?Mankind Pharma's shares fell 2% to Rs 1,985.50, despite the company announcing a 10% YoY rise in net profit to Rs 543 crore for the first q...
Mankind Pharma Q1 Results: Profit rises 10% YoY to Rs 543 croreMankind Pharma Q1 Results: Revenue from operations for the same period increased by 12% year-on-year (YoY) to Rs 2,893 crore, up from Rs 2,...
Motilal Oswal initiates coverage on Mankind Pharma with target price of Rs 2,650Motilal Oswal initiated coverage on Mankind Pharma with a 'buy' call and target price of Rs 2,650. The company's disruptive strategy in est...
Mankind Pharma Q3 Results: Cons PAT soars 60% YoY on robust all-round growthMankind Pharma Q3: Domestic revenue grew 20% YoY to Rs 2,400 crore, while exports more than doubled to Rs 207 crore. The strong domestic re...
Mankind Pharma shares jump 9% post Q1 earnings. Should you buy?The domestic business reported a robust 14% YoY growth in the quarter. The secondary sales saw an impressive growth of 12.5%, thereby outpe...
Mankind Pharma to acquire Panacea's formulation brands for India, NepalBoth the entities have entered into definitive agreements for the transaction involving a total consideration of Rs 1,872 crore. Panacea Bi...
Pet foods startup Dogsee Chew raises Rs 50 crore in Series A roundDogsee Chew said it will use the funds for brand building, R&D, and building a strong distribution network.
Mankind Pharma to open manufacturing plant in US, invest Rs 300 crore"We wish to become a multinational pharma company by tapping the foreign markets," Chairman and Founder RC Juneja said.
- Mankind forays into OTC market
Formulation drug maker Mankind Pharma has ventured into Rs 2,000 crore over-the-counter (OTC) market and will launch seven products in the ...
- Mankind Pharma to set up R&D units in HP, NCR
Pharmaceutical company, Mankind Pharma has said it will set up manufacturing and research facilities in Himachal Pradesh and National Capit...